Axonics® reports third quarter 2021 financial results

Irvine, calif.--(business wire)--axonics, inc. (nasdaq: axnx), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today reported financial results for the third quarter ended september 30, 2021. “we are pleased with this quarter's revenue result considering the significant impact the surge in covid-19 delta variant cases had on elective procedure volumes in august and september, in addition to staffing sh
AXNX Ratings Summary
AXNX Quant Ranking